U.S. seizes discontinued eyelash product

WASHINGTON Sat Nov 17, 2007 10:53am IST

Related Topics

WASHINGTON (Reuters) - U.S. marshals on Friday seized 12,682 applicator tubes of a discontinued cosmetic called Age Intervention Eyelash, which the Food and Drug Administration said could harm some users' vision.

The product -- once promoted as increasing eyelash growth -- had been sold and distributed by San Jose, California-based Jan Marini Skin Research, Inc, which accused the FDA of unfairly singling it out.

The FDA said it considered Age Intervention Eyelash "adulterated" and potentially dangerous, notably for users with elevated pressure inside the eye.

The product contains bimatoprost, an active ingredient in an FDA-approved drug to treat this condition.

For patients on the prescription drug, using Age Intervention Eyelash may boost the risk of optic nerve damage "because the extra dose of bimatoprost may decrease the prescription drug's effectiveness," the FDA said.

Jan Marini, the company's president and chief executive, said the product at issue had been in its warehouse since September 2006, when California public health authorities "embargoed" it at FDA request.

The company added in a statement it had offered to destroy the product, "but the FDA recently informed JMSR that it preferred to seize the product so that it could issue a press release announcing the seizure."

"We have been unfairly singled out," Marini said in a telephone interview. "Other companies use the same ingredient and we're not aware of any action that has been taken against them."

FDA spokesman Brad Swezey said in response, "As a matter of policy, we can't acknowledge whether any company is or is not the subject of an ongoing investigation."

The company said it had reformulated its eyelash product a year ago to eliminate the ingredient questioned by the FDA and had scrapped its marketing claims.

In its statement, the FDA said the sales value of the seized tubes was about $2 million and the marshals acted at the FDA's request.

Consumers, dermatologists and beauticians who may still have Age Intervention Eyelash should discontinue using it and discard it, FDA said.

It recommended consumers consult health-care providers if they have experienced any problems they suspect are related to the product's use.

"The agency takes seriously its responsibility to protect Americans from unapproved drugs," the statement said.

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Gaza Conflict

REUTERS SHOWCASE

Special Report

Special Report

Inside Xi Jinping's purge of China's oil mandarins.  Full Article 

Ferry Tragedy

Ferry Tragedy

S.Korea ferry businessman's cause of death impossible to decide - agency.  Full Article 

Food Scandal

Food Scandal

McDonald's takes chicken nuggets off menu in Hong Kong amid food scare.  Full Article 

Plane Crash

Plane Crash

Wreckage of Air Algerie plane carrying 116 people found in Mali.  Full Article 

Health Crisis

Health Crisis

Myanmar Muslims in remote Rakhine suffer worsening health crisis.  Full Article 

Afghan Election

Afghan Election

Afghan vote recount moves at snail's pace, rival sides far apart.  Full Article 

Iraq Government

Iraq Government

Iraq elects president as Ban urges unity to save nation.  Full Article 

MH17 Crash

MH17 Crash

Investigators find no evidence of MH17 black box tampering  Full Article 

Freedom at Last

Freedom at Last

Death row Christian woman flies out of Sudan, meets Pope.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage